Phosphoinositide 3-kinase in Health and Disease Volume 1 /

From humble beginnings over 25 years ago as a lipid kinase activity associated with certain oncoproteins, PI3K (phosphoinositide 3-kinase) has been catapulted to the forefront of drug development in cancer, immunity and thrombosis, with the first clinical trials of PI3K pathway inhibitors now in pro...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autor corporatiu: SpringerLink (Online service)
Altres autors: Rommel, Christian. (Editor, http://id.loc.gov/vocabulary/relators/edt), Vanhaesebroeck, Bart. (Editor, http://id.loc.gov/vocabulary/relators/edt), Vogt, Peter K. (Editor, http://id.loc.gov/vocabulary/relators/edt)
Format: Electrònic eBook
Idioma:English
Publicat: Berlin, Heidelberg : Springer Berlin Heidelberg : Imprint: Springer, 2011.
Edició:1st ed. 2011.
Periòdiques:Current Topics in Microbiology and Immunology, 346
Matèries:
Accés en línia:https://doi.org/10.1007/978-3-642-13663-4
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!